We Continue to Advance the TARGET Study with the Tricuspid Replacement Prosthesis Cardiovalve by Venus Medtech Europe

* Non-marketable product – CE marking to be issued soon

En World Medica, we are pleased to announce that we continue to add patients to the TARGET study, which evaluates the effectiveness and safety of the Tricuspid replacement prosthesis Cardiovalve from Venus Medtech Europe. This important study represents a step forward in the treatment of valvular heart disease and we are proud to contribute to its advancement.

We would especially like to congratulate the Valladolid team for their dedication, commitment and professionalism in this project. Dr. Ignacio J. Amat Santos and Dr. Sara Blasco Turrion have demonstrated enormous personal and professional quality in their work, which has been fundamental for the progress and success of the study at our institution.

We thank the entire team for their hard work and dedication, as well as Venus Medtech Europe for their collaboration and continued support in this important project.

Let’s continue to advance together in the research and treatment of heart diseases to improve the lives of our patients!